Document is current
Any future updates will be listed below
-
Authors
Ramos-Ramos, Juan Carlos
Lázaro-Perona, Fernando
Arribas, José Ramón
García-Rodríguez, Julio
Mingorance, Jesús http://orcid.org/0000-0001-6173-5711
Ruiz-Carrascoso, Guillermo
Borobia, Alberto M.
Paño-Pardo, José Ramón
Herruzo, Rafael
Arnalich, Francisco
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02307383 at ClinicalTrials.govDocuments that mention this clinical trial
Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae
https://doi.org/10.1186/s13099-020-00354-9
-
Funding
Funding for this research was provided by:
IdiPAZ (Desprobioxa)
Instituto de Salud Carlos III (PI13/01218, PI14/01832)
- License Information
-
More Information
Article History
Received: 15 October 2019
Accepted: 31 March 2020
First Online: 7 April 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of Hospital Universitario La Paz on May 8th, 2014, with code number: 4131 and EudraCT number: 2014-000449-65, and by the Spanish Drugs Agency, AEMPS, on July 7th, 2014. All the subjects included signed informed consent.
: Not applicable.
: The authors report no conflict of interest.
